Europe — EMA
Obodence (Denosumab)
Denosumab, the active ingredient in Obodence, is a monoclonal antibody presented as a injection for subcutaneous use. It treats osteoporosis and bone loss conditions in postmenopausal women and men at high risk of…
Request sourcing
What is Denosumab?
Denosumab, the active ingredient in Obodence, is a monoclonal antibody presented as a injection for subcutaneous use. It treats osteoporosis and bone loss conditions in postmenopausal women and men at high risk of fractures. GNH USA supplies Obodence as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres worldwide.
GNH USA supplies Obodence as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Denosumab used for?
Obodence acts on the RANK‑L pathway for bone remodel rem rem ... … g ........
- ... etc…
What are the side effects of Denosumab?
Common ...
What precautions apply to Denosumab?
...
